Search research articles
Contact Us
Filters
Showing results (101-110 of 675) with videos related to
Page
of 68
Sort By:
British Journal of Clinical Pharmacology
|
January 1, 1980
Bioavailability of standard and sugar-coated hydrallazine formulations in fast and slow acetylators [proceedings]
G M Hawksworth, M Morrice, J C Petrie, et al.
European Journal of Heart Failure
|
March 14, 2001
Altered diaphragm position and function in patients with chronic heart failure
L Caruana, M C Petrie, J J McMurray, et al.
British Journal of Clinical Pharmacology
|
April 1, 1989
Does a selective 5-hydroxytryptamine antagonist (ICI 169, 369) lower blood pressure in hypertensive patients?
A K Scott, P Roy-Chaudhury, J Webster, et al.
Lancet (London, England)
|
May 18, 1974
Letter: Conduct of clinical trials
D B Galloway, J C Petrie, K B Stewart, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
May 1, 1989
Computer-assisted shared care: the Aberdeen Blood Pressure Clinic
J C Petrie, J Webster, T A Jeffers, et al.
British Journal of Clinical Pharmacology
|
March 1, 1990
Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris
J Hosie, A K Scott, J C Petrie, et al.
Kidney International Reports
|
December 11, 2020
Transplant Renal Artery Stenosis
David P Baird, Jac Williams, Michaela C Petrie, et al.
Postgraduate Medical Journal
|
January 1, 1977
Clinical studies with atenolol in hypertension
J C Petrie, T A Jeffers, D B Galloway, et al.
British Medical Journal (Clinical Research Ed.)
|
May 16, 1987
Standards for blood pressure measuring devices
E O'Brien, J C Petrie, W A Littler, et al.
British Journal of Clinical Pharmacology
|
October 1, 1977
Atenolol once-daily in hypertension
T A Jeffers, J Webster, J C Petrie, et al.
Page
of 68
Search research articles
Search
Showing results (101-110 of 675) with videos related to
Sort By:
Page
of 68
British Journal of Clinical Pharmacology
|
January 1, 1980
Bioavailability of standard and sugar-coated hydrallazine formulations in fast and slow acetylators [proceedings]
G M Hawksworth, M Morrice, J C Petrie, et al.
European Journal of Heart Failure
|
March 14, 2001
Altered diaphragm position and function in patients with chronic heart failure
L Caruana, M C Petrie, J J McMurray, et al.
British Journal of Clinical Pharmacology
|
April 1, 1989
Does a selective 5-hydroxytryptamine antagonist (ICI 169, 369) lower blood pressure in hypertensive patients?
A K Scott, P Roy-Chaudhury, J Webster, et al.
Lancet (London, England)
|
May 18, 1974
Letter: Conduct of clinical trials
D B Galloway, J C Petrie, K B Stewart, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
May 1, 1989
Computer-assisted shared care: the Aberdeen Blood Pressure Clinic
J C Petrie, J Webster, T A Jeffers, et al.
British Journal of Clinical Pharmacology
|
March 1, 1990
Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris
J Hosie, A K Scott, J C Petrie, et al.
Kidney International Reports
|
December 11, 2020
Transplant Renal Artery Stenosis
David P Baird, Jac Williams, Michaela C Petrie, et al.
Postgraduate Medical Journal
|
January 1, 1977
Clinical studies with atenolol in hypertension
J C Petrie, T A Jeffers, D B Galloway, et al.
British Medical Journal (Clinical Research Ed.)
|
May 16, 1987
Standards for blood pressure measuring devices
E O'Brien, J C Petrie, W A Littler, et al.
British Journal of Clinical Pharmacology
|
October 1, 1977
Atenolol once-daily in hypertension
T A Jeffers, J Webster, J C Petrie, et al.
Page
of 68